Andolast free base - 10mM in DMSO , Calcium-activated potassium channel subunit alpha-1 activator, CAS No.132640-22-3, Calcium-activated potassium channel subunit alpha-1 activator
Disponible
SKU
A655764
Andolast (CR 2039) (free base) is an anti-allergic agent. Andolast can inhibit cAMP-phosphodiesterase with an IC 50 value of 50 μM. Andolast can be used for the research of asthma.
In Vivo
Andolast (CR 2039) (i.v. or i.m.) inhibits rat passive cutaneous anaphylaxis (PCA) with an ED 50 of 0.1 mg/kg . CR 2039 (10-100 mg/kg; i.v. or i.m.) inhibits the microvascular permeability changes in a model of allergic conjunctivitis in sensitized guinea-pigs . CR 2039 (0-1000 μM; i.v.) inhibits dose dependently guinea-pig lung cAMP-phosphodiesterase with an IC 50 value of 50 μM . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Hartley guinea-pigs (300-500 g) Dosage: 10-100 mg/kg Administration: I.M; I.V. Result: Showed dose-related significant protection against lgE-dependent bronchial anaphylaxis induced by aerosolized antigen in anesthetized guinea-pigs. Delayed dose dependently the onset of bronchoconstriction induced by aerosolized antigen.
Más Información
| CAS | 132640-22-3 |
|---|---|
| Concentración | 10mM in DMSO |
| Especificaciones y pureza | 10mM in DMSO |
| Condiciones de almacenamiento de almacenamiento | Store at -80°C |
| Enviado en | Dry ice packs + Cold packs |
| Product Description | Andolast (CR 2039) (free base) is an anti-allergic agent. Andolast can inhibit cAMP-phosphodiesterase with an IC 50 value of 50 μM. Andolast can be used for the research of asthma. In Vivo Andolast (CR 2039) (i.v. or i.m.) inhibits rat passive cutaneous anaphylaxis (PCA) with an ED 50 of 0.1 mg/kg . CR 2039 (10-100 mg/kg; i.v. or i.m.) inhibits the microvascular permeability changes in a model of allergic conjunctivitis in sensitized guinea-pigs . CR 2039 (0-1000 μM; i.v.) inhibits dose dependently guinea-pig lung cAMP-phosphodiesterase with an IC 50 value of 50 μM . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Hartley guinea-pigs (300-500 g) Dosage: 10-100 mg/kg Administration: I.M; I.V. Result: Showed dose-related significant protection against lgE-dependent bronchial anaphylaxis induced by aerosolized antigen in anesthetized guinea-pigs. Delayed dose dependently the onset of bronchoconstriction induced by aerosolized antigen. |
Reseñas
Reseñas de cliente
Remind me later